Investor FAQs
- Where is Codiak headquartered?
-
Codiak BioSciences, Inc.
35 CambridgePark Drive, Suite 500
Cambridge, MA 02140
+1 (617) 949-4100 - Where is the company incorporated?
-
Codiak is incorporated in Delaware.
- When was Codiak founded?
-
Codiak was founded in 2015.
- On what stock exchange are Codiak’s shares traded, what is the ticker symbol, and when did the Company go public?
-
Codiak stock is traded on the Nasdaq Global Market under the ticker CDAK. The initial public offering was on October 14, 2020.
- What is Codiak’s CUSIP number?
-
192010106
- Whom do I contact with questions about my stock? Who is Codiak’s transfer agent?
-
American Stock Transfer representatives can provide you with information about your account and assist with stock certificates, change of address and ownership transfer.
American Stock Transfer
6201 15th Avenue | Brooklyn, NY 11219
T: (800) 937-5449 - How do I buy shares of Codiak? Does the company have a direct purchase stock plan?
-
The Company’s common stock can be purchased through a securities broker of your choice. Codiak does not currently have a direct purchase stock plan.
- When does Codiak’s fiscal year end?
-
Codiak’s fiscal year ends on December 31st.
- Who are Codiak’s independent auditors?
-
Ernst & Young LLP
- How can I receive the latest corporate news releases and financial reports?
-
Codiak’s press releases and financial filings may be accessed from the investor section of our website. Additionally, you may sign up to receive email alerts from Codiak.
- Where can I find Codiak’s SEC filings? Where can I download and view quarterly and annual reports?
-
Quarterly and annual reports, as well as our other SEC filings, can be accessed on the Financials & Filings portion of the Investors page of our website or directly from the SEC at www.sec.gov.
- How do I contact Investor Relations with a request or question?
-
You may send an email to investor@codiakbio.com.